Research.Patient.info
High-risk prostate cancer research hub
2 indexed studies · 1 currently recruiting
- recruitingTherapeutic exploratory (Phase II)
An open label, single-arm, phase 2 study of neoadjuvant PEMbrolizumab before radical PROstatectomy (PEM-PRO) in high-risk prostate cancer patients
This study is looking at a new way to treat men with high-risk prostate cancer before surgery. It uses a drug called Pembrolizumab (Keytruda) to see if it can reduce the spread of cancer to lymph nodes, aiming for better outcomes than current treatments.
Italy - active not recruiting
COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)
This study looks at how well combined special scans (PSMA-PET/CT and MRI) can show prostate cancer inside the prostate, how far it's spread, and its aggressiveness in men with medium to high-risk prostate cancer, before removal surgery.
Austria · Belgium · Germany